Karyopharm Announces Clinical Data For Selinexor (KPT-330) In Advanced Solid Tumors
September 29, 2014 at 08:01 AM EDT
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, announced today the presentation of clinical ...